Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 6, 1993, Pages 1671-1676

  Amato, Giovanni ^a   Carella, Carlo ^a   Fazio, Serafino ^b   La Montagna, Giovanni ^a   Cittadini, Antonio ^b   Sabatini, Domenico ^b   Marciano Mone, Concetta ^a   Sacca, Luigi ^b   Bellastella, Antonio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEART DISEASE; HEART FUNCTION; HORMONE SUBSTITUTION; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; BODY COMPOSITION; BONE AND BONES; ELECTROCARDIOGRAPHY; FEMALE; GROWTH HORMONE; HEART; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOCARDIUM;

EID: 0027140982     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.6.8263158     Document Type: Article

References (36)

1. Jorgensen JOL. 1991 Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr Rev. 12:189-207.
2. LaFranchi S. 1992 Human growth hormone. Who is a candidate for treatment? Postgrad Med. 91:367-388.
3. Zadik Z, Stuart AC, McCarter RJ, Meistas M, Kowarski AA. 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 60:513-516.
4. Ho KY, Evans WS, Bllizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
5. Davidson MB. 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 8:115-131.
6. Binnerts A, Swart GR, Wilson JHP, et al. 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf). 37:79-87.
7. Degerblad M, Almkvist O, Grunditz R, et al. 1990 Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh). 123:185-193.
8. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. 1992 The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 37:387-397.
9. Rosen T, Bengtsson BA. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
10. Jorgensen JOL, Thuesen L, Ingemann-Hansen T, et al. 1989 Beneficial effects of growth hormone treatment in GH-defident adults. Lancet. 1:1221-1225.
11. Salomon F, Cuneo RC, Hesp R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone defidency. N Engl J Med. 321:1797-1803.
12. Sonksen PH, Cuneo RC, Salomon F, et al. 1991 Growth hormone therapy in adults with growth hormone defidency. Acta Paediatr Scand. 379(Suppl):139-146.
13. Whitehead HM, Boreman C, Mdlrath EM, et al. 1992 Growth hormone treatment of adults with growth hormone defidency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf). 36:45-52.
14. Segal KR, van Loan M, Fitzgerald PL Hodgdon JA, van Itallie TB. 1988 Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr. 47:714.
15. Nilas L, Norgaard H, Podenphant J, Gotfredsen A, Christiansen C. 1987 Bone composition in the distal forearm. Scand J Clin Lab Invest. 47:41-46.
16. Devereux RB, Reichek N. 1977 Echocardiographie determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55:613-618.
17. De Boer H, Blok GJ, Voerman HJ, De Vries PMJM, van der Veen EA. 1992 Body composition in adult growth hormone-defident men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab. 75:833-837.
18. Bengtsson BA, Brummer RJ, Bosaeus I. 1990 Growth hormone and body composition. Horn» Res. 33(Suppl 4): 19-24.
19. Christiansen JS, Jorgensen JO, Pedersen SA, Moller J, Jorgensen J, Skakkebaek NE. 1990 Effects of growth hormone on body composition in adults. Horn» Res. 33(Suppl 4):61-64.
20. Bengtsson B-A, Eden S, Lonn L, et al. 1993 Treatment of adults with growth hormone (GH) defidency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
21. Whitehead HM, Gilliland JS, Allen IV, Hadden DR. 1989 Growth hormone treatment in adults with growth hormone defidency: effed on muscle fibre size and proportions. Acta Paediatr Scand. 356(Suppl):65-67.
22. Cuneo RC, Salomon F, Wiles CM, et al. 1992 Histology of skeletal muscle in adults with GH defidency: comparison with normal muscle and response to GH treatment. Horm Res. 37:23-28.
23. van der Veen EA, Netelenbos JC. 1990 Growth hormone (replacement) therapy in adults: bone and caldum metabolism. Horm Res. 33(Suppl 4):65-68.
24. Bouillon R. 1991 Growth hormone and bone. Horm Res. 36(Suppl 1):49-55.
25. Stracke H, Schultz A, Moeller D, Rossol S, Schatz H. 1984 Effed of growth hormone on osteoblasts and demonstration of somatomedin C/IGF-I in bone organ culture. Acta Endocrinol (Copenh). 107:16-24.
26. Sartorio A, Conti A, Guzzaloni G, Faglia G. 1991 Serum osteocalcin levels in patients with GH defidency before and during GH treatment. Acta Paediatr Scand. 80:100-102.
27. Tapanainen P, Risteli L, Knip M, Kaar M, Risteli J. 1988 Serum aminoterminal propeptide of type III procollagen: a potential pre-didor of the response to growth hormone therapy. J Clin Endocrinol Metab. 67:1244-1249.
28. Johannsen JS, Pedersen SA, Jorgensen JO, et al. 1990 Effects of growth hormone (GH) on plasma bone gla protein in GH-defident adults. J Clin Endocrinol Metab. 70:916-919.
29. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. 1992 Bone mineral status in growth hormone-defident males with isolated and multiple pituitary defidendes of childhood onset. J Clin Endocrinol Metab. 74:118-123.
30. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M. 1992 Potent effed of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Ada Endocrinol (Copenh). 126:387-393.
31. Thuesen L, Christiansen JS, Sorensen KE, Jorgensen JOL, Orskov H, Henningsen P. 1988 Increased myocardial contractility following growth hormone administration in normal man. Dan Med Bull. 35:193-196.
32. Cuneo RC, Salomon F, Wilmshurst P, et al. 1991 Cardiovascular effects of growth hormone treatment in growth-hormone-defident adults: stimulation of the renin-aldosterone system. Clin Sd. 81:587-592.
33. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA. 1992 Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J. 67:92-96.
34. Barton JS, Cullen S, Hlndmarsh PC, Brook CGD, Preece MA. 1992 Growth hormone treatment in idiopathic short stature: a preliminary analysis of cardiovascular effects. Ada Paediatr. 383(Suppl):35-38.
35. Corpus E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
36. Orme SM, Sebastian JP, Oldroyd B, et al. 1992 Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin Endocrinol (Oxf). 37:453-459.